" class="no-js "lang="en-US"> Charlene Son Rigby - Medtech Alert
Friday, September 19, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Charlene Son Rigby

Charlene Son Rigby

About Charlene Son Rigby

Senior executive with over 15 years experience developing businesses at the intersection of data, technology, and healthcare.

Passion for driving product-market fit, growing revenue and building teams. Proven track record at Fortune 500 and startup companies. Diverse leadership roles spanning sales, marketing, product development, and business development.

Specialties: product management, sales, marketing, strategy, alliance management, analytics, artificial intelligence, bioinformatics, genetics, genomics, life sciences, healthcare, enterprise software, SaaS, startups, operations, change management, business transformation, business process re-engineering,

Related Story

Diseases

 Rarebase Launches a Neuroscience Drug Discovery Platform Collaborating with 15 Rare Disease Patient Organizations | Pharmtech Focus

Rarebase Launches a Neuroscience Drug Discovery Platform Collaborating with 15 Rare Disease Patient Organizations

September 15 2021

Rarebase, a public benefit biotechnology company, launched a tech-enabled drug discovery platform called Function. Function’s […]